Nanobodies and polypeptides against EGFR and IGF-IR

Details for Australian Patent Application No. 2006301426 (hide)

Owner Ablynx N.V.

Inventors Laeremans, Toon; De Haard, Hans; Hoogenboom, Hendricus Renerus Jacobus Mattheus

Agent Shelston IP

Pub. Number AU-A-2006301426

PCT Pub. Number WO2007/042289

Priority 60/725,939 11.10.05 US

Filing date 11 October 2006

Wipo publication date 19 April 2007

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

G01N 33/563 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving antibody fragments

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/042289 Priority application(s): WO2007/042289

11 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006301432-3,5-disubstituted phenyl-piperidines as modulators of dopamine neurotransmission

2006301423-Elastoplastic polyolefin compositions having low gloss